Sterile fluid pathway connection to drug containers for drug delivery pumps

US10369274B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10369274-B2
Application numberUS-201715651807-A
CountryUS
Kind codeB2
Filing dateJul 17, 2017
Priority dateSep 13, 2011
Publication dateAug 6, 2019
Grant dateAug 6, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A user-initiated fluid pathway connection includes: a connection hub, a piercing member, a sterile sleeve, and a drug container having a cap, a pierceable seal, a barrel, and a plunger seal, wherein the piercing member is initially retained within the sterile sleeve between the connection hub and the pierceable seal of the drug container. The connection hub may include an internal aperture within the connection hub which functions as a flow restrictor and wherein a piercing member is connected to one end of the internal aperture and a fluid conduit is connected to another end of the internal aperture. A drug delivery pump with integrated sterility maintenance features includes a housing, upon which an activation mechanism, an insertion mechanism, a fluid pathway connection as described above, a power and control system, and a drive mechanism connected to a drug container are mounted. Methods of assembly and operation are also provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A fluid pathway connection comprising: a drug container including a barrel having a proximal end and a distal end, a pierceable seal disposed at the proximal end of the barrel, and a cap disposed at the proximal end of the barrel; a piercing member; a fluid conduit; a connection hub, the piercing member being connected to the connection hub; and a sterile sleeve, one end of the sterile sleeve being fixedly coupled to the connection hub and an opposing end of the sterile sleeve being fixedly coupled to a proximal end of the drug container, the piercing member being disposed within a sterile environment defined by the sterile sleeve, the connection hub, and the pierceable seal, the piercing member being disposed between the connection hub and the pierceable seal of the drug container in an initial unactivated position, wherein the pierceable seal and the connection hub are adapted for relative movement between the initial unactivated position wherein the piercing member does not pierce the pierceable seal, and an activated position wherein the piercing member extends through the pierceable seal, the sterile sleeve being compressible or collapsible and adapted to compress or collapse as the connection hub and the pierceable seal are moved relatively between the initial unactivated position and the activated position, the piercing member being maintained in the sterile environment during movement from the initial unactivated position to the activated position. 2. The fluid pathway connection of claim 1 , wherein the drug container further includes a plunger seal. 3. The fluid pathway connection of claim 1 , wherein the pierceable seal has a seal barrier configured to be penetrated by the piercing member. 4. The fluid pathway connection of claim 3 , wherein the piercing member is initially disposed within the pierceable seal and in contact with, or adjacent to, the seal barrier. 5. The fluid pathway connection of claim 1 , wherein the piercing member extends through the connection hub. 6. The fluid pathway connection of claim 5 , wherein the fluid conduit is fluidly coupled to the piercing member opposite the pierceable seal. 7. The fluid pathway connection of claim 1 , wherein the sterile sleeve is a pre-formed aspect of the pierceable seal. 8. The fluid pathway connection of claim 1 , wherein the sterile sleeve is connected to the connection hub by engagement between hub connectors of the sterile sleeve and corresponding sleeve connectors of the connection hub. 9. The fluid pathway connection of claim 1 , further including an activation mechanism. 10. The fluid pathway connection of claim 9 , wherein the activation mechanism includes a button. 11. The fluid pathway connection of claim 9 , wherein the activation mechanism is disposed along an axis of the connection hub. 12. The fluid pathway connection of claim 11 , wherein displacement of the activation mechanism by a user causes displacement of the connection hub to cause the piercing member to penetrate the pierceable seal. 13. The fluid pathway connection of claim 11 , wherein the connection hub is disposed along an axis of the barrel. 14. The fluid pathway connection of claim 1 , wherein the connection hub is disposed along an axis of the barrel. 15. The fluid pathway connection of claim 14 , wherein the connection hub, the piercing member, and the barrel are substantially coaxially disposed. 16. The fluid pathway connection of claim 1 , wherein the connection hub includes an internal aperture, the piercing member and the fluid conduit being fluidly connected at opposite ends of the internal aperture of the connection hub, the internal aperture having at least one of: a smaller internal diameter than the fluid conduit to restrict the flow of a drug fluid passing therethrough, and a circuitous or tortuous path within the connection hub to extend a fluid pathway through the internal aperture. 17. A drug delivery pump with integrated sterility maintenance features comprising: the fluid pathway connection of claim 2 ; a housing; an assembly platform; an activation mechanism disposed on the assembly platform; an insertion mechanism disposed on the assembly platform; a power and control system disposed on the assembly platform; and a drive mechanism disposed on the assembly platform, the drive mechanism initially coupled to the drug container or adapted to be coupled to the drug container. 18. The drug delivery pump of claim 17 , wherein the drug container contains a drug fluid. 19. The drug delivery pump of claim 17 , wherein the piercing member, the pierceable seal and the barrel are substantially coaxially disposed. 20. The drug delivery pump of claim 17 , wherein the piercing member, the pierceable seal and the activation mechanism are substantially coaxially disposed. 21. A fluid pathway connection comprising: a drug container including a barrel having a proximal end and a distal end, a pierceable seal disposed at the proximal end of the barrel, and a cap disposed at the proximal end of the barrel; a piercing member; a fluid conduit; a connection hub, the piercing member being connected to the connection hub; and a sterile sleeve, one end of the sterile sleeve being fixedly coupled to the connection hub and an opposing end of the sterile sleeve being fixedly coupled to a proximal end of the drug container, the sterile sleeve being a pre-formed aspect of the pierceable seal, the piercing member being disposed within the sterile sleeve between the connection hub and the pierceable seal of the drug container in an initial unactivated position, wherein the pierceable seal and the connection hub are adapted for relative movement between the initial unactivated position wherein the piercing member does not pierce the pierceable seal, and an activated position wherein the piercing member extends through the pierceable seal, the sterile sleeve being compressible or collapsible and adapted to compress or collapse as the connection hub and the pierceable seal are moved relatively between the initial unactivated position and the activated position. 22. A drug delivery pump with integrated sterility maintenance features comprising: a fluid pathway connection including: a drug container including: a barrel having a proximal end and a distal end, a pierceable seal disposed at the proximal end of the barrel, and a cap disposed at the proximal end of the barrel; a piercing member; a fluid conduit; a connection hub, the piercing member being connected to the connection hub; and a sterile sleeve, one end of the sterile sleeve being fixedly coupled to the connection hub and an opposing end of the sterile sleeve being fixedly coupled to a proximal end of the drug container, the piercing member being disposed within the sterile sleeve between the connection hub and the pierceable seal of the drug container in an initial unactivated position, wherein the pierceable seal and the connection hub are adapted for relative movement between the initial unactivated position wherein the piercing member does not pierce the pierceable seal, and an activated position wherein the piercing member extends through the pierceable seal, the sterile sleeve being compressible or collapsible and adapted to compress or collapse as the connection hub and the pierceable seal are moved relatively between the initial unactivated position and the activated position; a housing; an assembly platfor

Assignees

Inventors

Classifications

  • by controlling the degree of opening of the flow line · CPC title

  • Needle sets, i.e. connections by puncture between reservoir and tube {; Connections between reservoir and tube (in jet-action syringes A61M5/30; connectors for tubes having sealed ends and a needle for piercing them A61M39/14)} · CPC title

  • Adjusting flow; Devices for setting a flow rate · CPC title

  • Right-angle needle-type devices · CPC title

  • of the skin patch type · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10369274B2 cover?
A user-initiated fluid pathway connection includes: a connection hub, a piercing member, a sterile sleeve, and a drug container having a cap, a pierceable seal, a barrel, and a plunger seal, wherein the piercing member is initially retained within the sterile sleeve between the connection hub and the pierceable seal of the drug container. The connection hub may include an internal aperture with…
Who is the assignee on this patent?
Unl Holdings Llc
What technology area does this patent fall under?
Primary CPC classification A61M5/14248. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).